40 results
8-K
EX-99.4
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
caused, personal injury or death. Elicio will face an even greater risk of product liability if it receives marketing approval for and commercialize any … if:
they are incident to a physician’s services;
they are reasonable and necessary for the diagnosis or treatment of the illness or injury for which
424B3
ELTX
Elicio Therapeutics Inc.
28 Apr 23
Prospectus supplement
4:07pm
, and claims could be brought against it if the use or misuse of one of its product candidates causes, or merely appears to have caused, personal injury … to a physician’s services;
they are reasonable and necessary for the diagnosis or treatment of the illness or injury for which they are administered
S-4/A
EX-10.27
rz5lx xfp9hk9vmcde
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.28
888fpe7qgw
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.34
25hsrd86o0ev pz8
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.25
nc21dw a8
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
m5pon 0vb
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
8-K
EX-99.1
gul6ey9
30 Mar 22
Angion Provides Corporate Update and Reports Full Year 2021 Financial Results
4:52pm
8-K
EX-99.1
6k2jdkza
12 Nov 21
Angion Provides Corporate Update and Reports Third Quarter 2021 Financial Results
7:05am